Chronic Obstructive Pulmonary Disease (Copd): Emerging Therapies
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by increasing breathlessness. COPD includes conditions like emphysema and chronic bronchitis, where airflow is obstructed, making breathing difficult. It is a leading cause of morbidity and mortality worldwide, with significant impacts on quality of life and healthcare costs. According to the World Health Organization (WHO), over 65 million people suffer from moderate to severe COPD globally, with the disease accounting for approximately 3 million deaths each year. According to UnivDatos Market Insights, The Chronic Obstructive Pulmonary Disease Market was valued at approximately USD 13 Billion in 2023 and is expected to grow at a strong CAGR of around ~5% during the forecast period (2024-2032). For More Detailed Analysis in PDF Format, Visit- https://univdatos.com/get-a-free-sample-form-php/?product_id=62811 Understanding COPD COPD is primarily caused by long-term exposure to irritate gases...